D. Frye
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
- Cancer Research top 2%
- Breast Cancer Treatment Studies
Papers in
- Oncology 15
- Cancer Treatment and Pharmacology 13
- Neutropenia and Cancer Infections 3
- Cancer Diagnosis and Treatment 2
-
- Breast Cancer Treatment Studies 10
- Co-authors
- Aman U. Buzdar (14 shared papers)Gabriel N. Hortobágyi (10 shared papers)Terry L. Smith (2 shared papers)L. D. Ziegler (2 shared papers)Frankie A. Holmes (4 shared papers)A. U. Buzdar (4 shared papers)G. N. Hortobágyi (4 shared papers)R S Walters (3 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Annals of Oncology (3 papers)Cancer (2 papers)The Breast (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
D. Frye
22 papers receiving 1.9k citations
D. Frye's Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 1.2k
- Cancer Research 561
- Dermatology 109
- Pulmonary and Respiratory Medicine 282
- Hematology 88
Countries citing papers authored by D. Frye
This map shows the geographic impact of D. Frye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Frye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Frye more than expected).
Fields of papers citing papers by D. Frye
This network shows the impact of papers produced by D. Frye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Frye. The network helps show where D. Frye may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Frye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer Hit paper breakdown → | 1991 | 616 |
| 2 | Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. Hit paper breakdown → | 1996 | 596 |
| 3 | 1989 | 149 | |
| 4 | 1997 | 122 | |
| 5 | 1987 | 102 | |
| 6 | 1996 | 99 | |
| 7 | 2007 | 57 | |
| 8 | The M. D. Anderson Cancer Center experience with Taxol in metastatic breast cancer. | 1993 | 45 |
| 9 | Capecitabine: nursing implications of a new oral chemotherapeutic agent. | 1999 | 38 |
| 10 | 1998 | 28 | |
| 11 | 1999 | 14 | |
| 12 | 1994 | 11 | |
| 13 | Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer. | 1997 | 10 |
| 14 | Phase II study of iproplatin in metastatic breast carcinoma. | 1987 | 9 |
| 15 | 1996 | 7 | |
| 16 | 1991 | 5 | |
| 17 | 1990 | 4 | |
| 18 | 2004 | 4 | |
| 19 | 2005 | 3 | |
| 20 | Reutilization of doxorubicin in patients with progressive metastatic breast cancer | 1989 | 3 |
About D. Frye
D. Frye is a scholar working on Oncology, Cancer Research, Dermatology, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 22 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (13 papers), Breast Cancer Treatment Studies (10 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Chemotherapy-related skin toxicity (3 papers), Neutropenia and Cancer Infections (3 papers), Estrogen and related hormone effects (2 papers), Cancer Diagnosis and Treatment (2 papers) and Breast Lesions and Carcinomas (2 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (561 citations), Dermatology (109 citations), Pulmonary and Respiratory Medicine (282 citations) and Hematology (88 citations). D. Frye has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Aman U. Buzdar, Gabriel N. Hortobágyi, Terry L. Smith, L. D. Ziegler, Frankie A. Holmes, A. U. Buzdar, G. N. Hortobágyi, R S Walters, R. Theriault and Martin N. Raber. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer, The Breast and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.